Neoadjuvant Cabozantinib in an Unresectable Locally Advanced Renal Cell Carcinoma Patient Leads to Downsizing of Tumor Enabling Surgical Resection: A Case Report

Overview of attention for article published in Frontiers in oncology, February 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (70th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

twitter: 9 X users

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 8 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 9 X posts from 9 X users, with an upper bound of 38,546 followers.

RT @FrontOncology: New research: Neoadjuvant Cabozantinib in an Unresectable Locally Advanced Renal Cell Carcinoma Patient Leads to Downsiz…

09 Mar 2021

Reply Repost Favourite

New research: Neoadjuvant Cabozantinib in an Unresectable Locally Advanced Renal Cell Carcinoma Patient Leads to Downsizing of Tumor Enabling Surgical Resection: A Case Report: Introduction Cabozantinib (XL-184) is a small molecule inhibitor of… https://t.

09 Mar 2021

Reply Repost Favourite

RT @virajmaster: Fascinating data, and congrats to the team. I especially like their presentation of the trajectory of each individual pat…

17 Feb 2021

Reply Repost Favourite

RT @virajmaster: Fascinating data, and congrats to the team. I especially like their presentation of the trajectory of each individual pat…

17 Feb 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.